Childhood onset systemic lupus erythematosus: how is it different from adult SLE?

Area of Science:

• Pediatric Rheumatology
• Immunology
• Systemic Lupus Erythematosus (SLE)

Background:

• Approximately 20% of SLE cases manifest in childhood, with a less pronounced female predominance compared to adults.
• Children often present with more severe systemic involvement, including nephritis, neuro-psychiatric disease, and cytopenias.
• Diagnosing a chronic, unpredictable disease like SLE during adolescence presents significant psychosocial challenges.

Purpose of the Study:

• To review the distinct clinical and immunological features of childhood SLE.
• To compare and contrast childhood SLE with its adult counterpart.
• To highlight the specific medical and social needs of pediatric SLE patients for optimal outcomes.

Main Methods:

• Review of clinical and immunological aspects of childhood SLE.
• Comparison of presentation, manifestations, and treatment outcomes between pediatric and adult SLE patients.
• Analysis of long-term sequelae and treatment toxicities in children with SLE.

Main Results:

• Childhood SLE exhibits unique systemic manifestations, including higher rates of nephritis, neuro-psychiatric disease, and cytopenias at presentation.
• Current treatments (steroids, immunosuppressants) have improved 10-year survival to nearly 90% but are associated with significant toxicity.
• Children experience more cumulative damage over their longer lifespans due to earlier disease onset.

Conclusions:

• Childhood SLE requires tailored management strategies recognizing the specific needs of adolescents.
• While survival has improved, the development of therapies that minimize disease activity, damage, and toxicity without compromising growth and fertility is crucial.
• Understanding the differences between childhood and adult SLE is essential for effective long-term care.